LONG-TERM FOLLOW-UP OF CONTEMPORARY TREATMENT IN EARLY-STAGE HODGKIN LYMPHOMA (HL): UPDATED ANALYSES OF THE GERMAN HODGKIN STUDY GROUP HD7, HD8, HD10 AND HD11 TRIALS

被引：0
|
作者：
Broeckelmann, P. J.
Goergen, H.
Pluetschow, A.
Kreissl, S.
Buerkle, C.
Borchmann, S.
Fuchs, M.
Borchmann, P.
Engert, A.
机构：
[1] Univ Hosp Cologne, Dept Internal Med, Cologne, Germany
[2] Univ Hosp Cologne, German Hodgkin Study Grp GHSG, Cologne, Germany
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S106
引用
收藏
页码：4 / 4
页数：1
相关论文
共 50 条
  • [31] Combined modality treatment with intensified chemotherapy and dose-reduced involved field radiotherapy in patients with early unfavourable Hodgkin Lymphoma (HL): Final analysis of the German Hodgkin Study Group (GHSG) HD11 trial
    Borchmann, P.
    Diehl, V
    Goergen, H.
    Mueller, H.
    Mueller, R. P.
    Eich, H.
    Mueller-Hermelink, K.
    Herrmann, R.
    Markova, J.
    Ho, A.
    Hiddemann, W.
    Doerken, B.
    Greil, R.
    Engert, A.
    ONKOLOGIE, 2010, 33 : 125 - 125
  • [32] COMBINED MODALITY TREATMENT WITH INTENSIFIED CHEMOTHERAPY AND DOSE-REDUCED INVOLVED FIELD RADIOTHERAPY IN PATIENTS WITH EARLY UNFAVOURABLE HODGKIN LYMPHOMA (HL): FINAL ANALYSIS OF THE GERMAN HODGKIN STUDY GROUP (GHSG) HD11 TRIAL
    Engert, A.
    Borchmann, P.
    Diehl, V.
    Goergen, H.
    Mueller, H.
    Mueller, R.
    Eich, H.
    Mueller-Hermelink, H.
    Herrmann, R.
    Markova, J.
    Ho, A.
    Hiddemann, W.
    Doerken, B.
    Greil, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 167 - 167
  • [33] Assessment of gonadal function and fertility in survivors after Hodgkin Lymphoma (HL) treatment within the German Hodgkin Study Group (GHSG) HD13-15 trials
    Behringer, K.
    Mueller, H.
    Goergen, H.
    Thielen, I
    Eibl, A. D.
    Stumpf, V
    Wessels, C.
    Wiehlpuetz, M.
    Rosenbrock, J.
    Halbsguth, T.
    Reiners, K. S.
    Schober, T.
    Renno, J. H.
    von Wolff, M.
    van der Ven, K.
    Kuehr, M.
    Fuchs, M.
    Diehl, V
    Engert, A.
    Borchmann, P.
    ONKOLOGIE, 2012, 35 : 9 - 9
  • [34] Two cycles of ABVD followed by involved field radiotherapy with 20 Gray (Gy) is the new standard of care in the treatment of patients with early-stage Hodgkin lymphoma: final analysis of the randomized German Hodgkin Study Group (GHSG) HD10 study
    Engert, A.
    Diehl, V
    Pluetschow, A.
    Eich, H.
    Herrmann, R.
    Doerken, B.
    Kanz, L.
    Greil, R.
    Markova, J.
    Fuchs, M.
    Borchmann, P.
    Mueller-Hermeling, H. K.
    Mueller, R. P.
    ONKOLOGIE, 2010, 33 : 124 - 124
  • [35] TWO CYCLES OF ABVD FOLLOWED BY INVOLVED FIELD RADIOTHERAPY WITH 20 GRAY (GY) IS THE NEW STANDARD OF CARE IN THE TREATMENT OF PATIENTS WITH EARLY-STAGE HODGKIN LYMPHOMA: FINAL ANALYSIS OF THE RANDOMIZED GERMAN HODGKIN STUDY GROUP (GHSG) HD10 STUDY
    Engert, A.
    Pluetschow, A.
    Eich, H.
    Herrmann, R.
    Doerken, B.
    Kanz, L.
    Greil, R.
    Markova, J.
    Fuchs, M.
    Borchmann, P.
    Mueller-Hermelink, H.
    Mueller, R.
    Diehl, V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 473 - 473
  • [36] Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial
    Behringer, K.
    Thielen, I.
    Mueller, H.
    Goergen, H.
    Eibl, A. D.
    Rosenbrock, J.
    Halbsguth, T.
    Eichenauer, D. A.
    Fuchs, M.
    Reiners, K. S.
    Renno, J. H.
    van der Ven, K.
    Kuehr, M.
    von Wolff, M.
    Diehl, V.
    Engert, A.
    Borchmann, P.
    ANNALS OF ONCOLOGY, 2012, 23 (07) : 1818 - 1825
  • [37] Involved field(IF) vs. extended field (EF) radiotherapy (RT) for patients in early unfavorable stages of Hodgkin's lymphoma (HL): 10-year update of the HD8 trial of the German Hodgkin Study Group (GHSG)
    Kriz, J.
    Sasse, S.
    Klimm, B.
    Goergen, H.
    Mueller, R. -P
    Diehl, V
    Borchmann, P.
    Engert, A.
    Eich, H. -T
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 30 - 30
  • [38] A LONG-TERM FOLLOW-UP REPORT ON THE MODIFIED PEDIATRIC PROTOCOL DAL-HD-90 FOR ADOLESCENTS AND YOUNG ADULTS WITH HODGKIN LYMPHOMA
    Semochkin, Sergey V.
    Arshanskay, Evgeniya G.
    Bobkova, Maria M.
    Rumiantsev, Alexander G.
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1042 - 1042
  • [39] PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 By the German Hodgkin Study Group
    Fuchs, Michael
    Goergen, Helen
    Kobe, Carsten
    Eich, Hans
    Baues, Christian
    Greil, Richard
    Sasse, Stephanie
    Zijlstra, Josee M.
    Lohri, Andreas
    Rosenwald, Andreas
    von Tresckow, Bastian
    Diehl, Volker
    Kuhnert, Georg
    Dietlein, Markus
    Borchmann, Peter
    Engert, Andreas
    BLOOD, 2018, 132
  • [40] More Chemotherapy Does Not Obviate the Need for Radiation Therapy (RT): Treatment for Early-Stage Favorable Hodgkin Lymphoma According to the HD10 Trial Compared With Chemotherapy Alone
    Pinnix, C. C.
    Abou Yehia, Z.
    Smith, G. L.
    Milgrom, S. A.
    Ho, J. C.
    Reddy, J.
    Gunther, J. R.
    Akhtari, M.
    Osborne, E. M.
    Medeiros, L. J.
    Fanale, M.
    Dabaja, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E489 - E490
12345